XML 53 R33.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity Incentive Plans (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Restricted Stock Units Activity  

A summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in the table below:

 

 

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
                
Outstanding, December 31, 2018   65,782   $21.00   $730,185 
Granted   -    -      
Vested and settled with share issuance   (7,467)  $27.15      
Forfeited/canceled   (7,982)  $26.85      
Outstanding, December 31, 2019   50,333   $19.20   $- 
Outstanding, December 31, 2019   50,333   $19.20   $- 
Granted   -    -      
Vested and settled with share issuance   (45,000)  $18.15      
Forfeited/canceled   (5,333)  $27.00      
Outstanding, December 31, 2020   -     -   $- 
Schedule of Incentive Bonus Awards Granted to Employees  

A summary of the incentive stock bonus awards granted to employees under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in the table below:

 

 

Number of

Shares

  

Weighted

Average Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
               
Unvested, December 31, 2018   11,200   $16.80   $124,320 
Awarded   -    -      
Vested   (11,200)  $16.80      
Forfeited   -    -      
Unvested, December 31, 2019   -    -      
Awarded   -    -      
Vested   -    -      
Forfeited   -    -      
Unvested, December 31, 2020   -    -      
2017 Equity Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock Option Activity  

A summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term  

Aggregate Intrinsic

Value

 
                 
Outstanding, December 31, 2018   70,400   $15.60    8.4   $           - 
Granted   13,333   $12.00          
Exercised   -    -           
Forfeited   (16,055)  $17.40           
Expired   (111)  $15.75           
Outstanding, December 31, 2019   67,567   $14.40    7.7   $- 
Granted   44,113   $10.50    10.0    - 
Exercised   -                
Forfeited   -                
Expired   (16,673)  $15.15    4.3      
Outstanding, December 31, 2020   95,007   $12.45    8.3   $- 
Exercisable, December 31, 2020   95,007   $12.45    8.3   $- 
Summary of Non-vested Non-qualified Stock Option Activity  

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are presented in the table below:

 

  Number of
Options
   Weighted
Average
Grant-Date
Fair Value
   Aggregate
Intrinsic
Value
   Grant-Date
Fair Value
 
                
Nonvested, December 31, 2018   48,889   $12.90   $        -   $628,756 
Granted   13,333   $9.75        $130,120 
Vested   (32,833)  $11.10        $362,998 
Forfeited   (16,056)  $15.30        $246,344 
Expired   -    -        $- 
Nonvested, December 31, 2019   13,333   $11.25   $-   $149,534 
Granted   44,113   $8.85        $387,199 
Vested   (57,446)  $9.30        $536,733 
Forfeited   -             $- 
Expired   -             $- 
Nonvested, December 31, 2020   -        $-   $- 
2017 Equity Plan [Member] | Director [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock Option Activity  

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan during the years ended December 31, 2020 and 2019 are presented in the table below:

 

  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
                     
Outstanding, December 31, 2018   6,000   $20.25    8.6   $          - 
Granted   -    -           
Exercised   -    -           
Forfeited/Cancelled   -    -           
Expired   -    -           
Outstanding, December 31, 2019   6,000   $20.25    7.6   $- 
Granted   43,333   $8.55    8.5      
Exercised   -    -           
Forfeited/Cancelled   -    -           
Expired   -    -           
Outstanding, December 31, 2020   49,333   $10.05    7.5   $- 
Exercisable, December 31, 2020   42,667   $10.95    8.0   $- 
Summary of Non-vested Non-qualified Stock Option Activity  

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan for the years ended December 31, 2020 and 2019 are presented in the table below:

 

  Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                    
Nonvested, December 31, 2019   -    -   $-      
Granted   -    -           
Vested   -    -           
Forfeited   -    -           
Expired   -    -           
Nonvested, December 31, 2019   -    -   $-    -  
Granted   43,333    8.55        $373,000 
Vested   (36,667)   9.45        $344,000 
Forfeited   -    -        $- 
Expired   -    -        $- 
Nonvested, December 31, 2020   6,666    4.35   $5,800   $29,000 
2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to employees and consultants under the 2017 Equity Plan during the nine months ended September 30, 2021, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2020   95,007   $12.45    8.3   $     - 
Granted   20,239   $12.75    10.0   $- 
Exercised   -                
Forfeited   (1,914)  $18.30    6.6   $- 
Expired   -                
Outstanding, September 30, 2021   113,332   $12.45    7.9   $- 
Exercisable, September 30, 2021   101,665   $12.75    7.7   $- 
 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for employees and consultants under the 2017 Equity Plan for the nine months ended September 30, 2021, are presented in the table below:

 

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2020   -   $-   $-   $- 
Granted   20,239   $12.30   $-   $- 
Vested   (8,572)  $16.80   $66,412   $- 
Forfeited   -             $- 
Expired   -             $- 
Nonvested, September 30, 2021   11,667   $9.15   $-   $104,800 
 
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and the 2021 Equity Plan, during the nine months ended September 30, 2021, are presented in the table below:

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2020   49,333   $10.05    7.5   $     - 
Granted   1,538   $9.75    10.0   $- 
Exercised   -                
Forfeited/Cancelled   -                
Expired   -                
Outstanding, September 30, 2021   50,871   $10.05    6.8   $- 
Exercisable, September 30, 2021   50,871   $10.05    6.8   $- 
 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan, for the nine months ended September 30, 2021, are presented in the table below:

 

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                
Nonvested, December 31, 2020   6,667   $4.35   $31,000   $- 
Granted   1,538    9.75   $(1,154)  $- 
Vested   (8,205)  $5.40   $(29,846)  $- 
Forfeited   -                        
Expired   -                
Nonvested, September 30, 2021   -        $-   $-